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Abstract
A potential relationship between postoperative urinary tract infection (UTI) and surgical site infection (SSI) following posterior spinal fusion
and instrumentation (PSFI) was investigated. A retrospective review was performed of prospectively collected demographic, clinical and
microbiological data of 466 consecutive patients (median age, 53.7 years (interquartile range (IQR) 33.8–65.6); 58.6% women) undergoing
PSFI to identify those with UTI in the ﬁrst 4 weeks and SSI in the ﬁrst 12 weeks after PSFI. Overall, 40.8% had an American Society of
Anesthesiologists score of >2, and 49.8% had undergone fusion of more than three segments. Eighty-nine patients had UTI, 54 had SSI, and
22 had both conditions. In nine of the 22 (38%) cases, the two infections were caused by the same microorganism. The urinary tract was the
probable source of SSI by Gram-negative bacteria in 38% (8/21) of cases. On multivariate analysis, UTI (OR 3.1, 95% CI 1.6–6.1; P 0.001)
and instrumentation of more than three segments (OR 2.7, 95% CI 1.1–6.3; P 0.024) were statistically associated with SSI. Patients
receiving ciproﬂoxacin for UTI had higher microbial resistance rates to ﬂuoroquinolones at SSIs (46.13%) than those without ciproﬂoxacin
(21.9%), although the difference did not reach statistical signiﬁcance (p 0.1). In our series, UTI was signiﬁcantly associated with SSI after PSFI.
On the basis of our results, we conclude that further efforts to reduce the incidence of postoperative UTI and provide adequate empirical
antibiotic therapy that avoids quinolones whenever possible may help to reduce SSI rates and potential microbial resistance.
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Introduction
Spinal surgery rates are progressively increasing, and this has
led to more frequent presentation of surgery-related compli-
cations, such as surgical site infection (SSI). Staphylococcus
aureus and, in general, Gram-positive bacteria are the most
common causal microorganisms of SSI after instrumented
spinal surgery, but the number of reports describing higher
rates of SSI caused by Gram-negative bacteria (GNB) has
clearly increased [1].
GNB are not found among the patient’s skin ﬂora, but are
present in the area surrounding the urogenital tract; hence,
SSIs caused by GNB are often thought to originate from a
urinary tract source [2]. In their study investigating perioper-
ative complications in elderly patients undergoing spine
surgery, Carreon et al. [3] found wound infection to be the
most common major complication (10%) and urinary tract
infection (UTI) the most common minor one (34%). UTI has
also been speciﬁcally reported as the most frequent compli-
cation following adult surgery for deformity [4].
Postoperative UTI and SSI are both major concerns, and
several reports have demonstrated an association between
preoperative urinary tract colonization and later development
of SSI following instrumented spinal surgery [5–7]. However,
to our knowledge, there are no in-depth studies examining a
potential relationship between these two infectious complica-
tions in the postoperative period.
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We set out to investigate whether the presence of
postoperative UTI increases the risk of developing SSI, and
in what way these infections may be related. We also
examined the antibiotic susceptibility patterns of the causal
isolates and the implications regarding empirical antibiotic
treatment for UTI and SSI.
Materials and Methods
Sample
We performed a retrospective review of prospectively
collected data including all patients from the Spinal Surgery
Registry of a single institution (tertiary referral centre)
undergoing thoracic and/or lumbar posterior spinal fusion
and instrumentation (PSFI) between January 2008 and Decem-
ber 2010. Patients undergoing cervical spine surgery were
excluded because of the known signiﬁcantly lower risk of SSI
[8]. Patient-related and surgery-related data were prospec-
tively recorded: age, sex, diagnosis, American Society of
Anesthesiologists (ASA) score, preoperative neurogenic blad-
der or incontinence, number of instrumented segments, and
whether fusion included the sacrum or pelvic region. The
diagnosis of SSI according to the CDC/NHS deﬁnitions [9] had
also been recorded. Speciﬁc data on comorbidities, body mass
index, diabetes mellitus and smoking were not available in the
registry. All patients had at least 1 year of follow-up to ensure
that no SSI case was overlooked.
Patients received standard antibiotic prophylaxis with
cefazolin [10], with redosing every 3 h in longer operations
and when blood loss exceeded 1500 mL. In patients with
neurogenic bladder or a preoperative indwelling catheter,
urine testing was performed before surgery. When coloniza-
tion by Gram-negative microorganisms was observed, it was
treated, and broad-spectrum antibiotic prophylaxis was
administered.
All samples processed by the Microbiology Department for
each patient during the ﬁrst 3 months after the index surgery
were reviewed to detect UTI and SSI as deﬁned below. Blood
culture results of patients presenting with SSI were registered,
and bacteraemia was sought for.
All patients were treated by the same team in a uniform
manner. Four surgeons performed the operations. Skin
preparation was carried out with povidone-iodine. Urinary
catheterization was performed before surgery. During the
postoperative course, closed suction drains and indwelling
catheters were routinely removed 48 h after surgery. No
extra antibiotics were administered during the insertion or
removal of urinary catheters. However, patients with incon-
tinence or neurogenic bladder had longer catheterization
times, depending on their bladder function. Catheterization
time was not recorded in the registry.
During the postoperative course, urine culture was not
carried out on a routine basis. Urinary bacterial count was
performed if dysuria, fever or other symptoms raised the
suspicion of UTI, according to the criteria of the attending
clinician. In cases with leukocyturia of >30 cells/lL, urine
culture was performed. Empirical antibiotic treatment was
initiated in all patients with clinically suspected UTI, and was
then changed if the antibiogram showed resistance to the
empirical therapy.
Surgical site cultures were taken in debridement proce-
dures performed for suspected SSI. Some patients showing
signs of infection (redness, swelling, pain, and secretion) were
diagnosed by the treating physician as having superﬁcial SSI
according to the CDC/NHS deﬁnitions [9], and culture
specimens were taken in sterile conditions. The microorgan-
ism(s) and their antibiotic susceptibility patterns were
recorded to conﬁrm the adequacy of the antibiotic therapy
administered.
Deﬁnitions
UTI was established by the presence of consistent clinical
symptoms and/or fever with no other infectious foci, leuko-
cyturia (>30 cells/lL), and a positive urine culture with a
bacterial count of 105 during the ﬁrst 4 weeks after PSFI.
Patients with UTIs occurring after the onset of SSI were
excluded from the analysis, as this could act as a confounding
factor in determining a causative relationship between UTI and
SSI.
SSI was deﬁned as clinical signs and symptoms of suspicion
(e.g. fever and purulent drainage), conﬁrmed by positive
culture of wound site specimens after the index procedure, in
keeping with the CDC/NHSN deﬁnition [9]. Only SSIs
presenting within the ﬁrst 12 weeks were included.
Statistical analysis
The median and interquartile range (IQR) were calculated for
continuous variables, and percentage and 95% CI for categor-
ical variables. The variables ‘ASA score’ and ‘number of
instrumented segments’ were dichotomized, taking the median
value as the cut-off: >2 for ASA score, and >3 for number of
instrumented segments. The chi-square test or Fisher exact
test was used to compare categorical variables, and the Mann–
Whitney U-test was used for continuous variables. All
statistical tests were two-tailed, and the threshold of statistical
signiﬁcance was p <0.05. For all potential risk factors, an
individual OR with the associated 95% CI and p-value was
calculated. To identify independent risk factors for SSI,
sequential multivariate logistic regression analysis was
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performed. Variables with p-values of <0.1 in the univariate
analysis were eligible for inclusion in the multivariate models.
The goodness-of-ﬁt of the ﬁnal model was evaluated with the
Hosmer–Lemeshow C-test. To assess the predictive perfor-
mance of the ﬁnal model, the area under the receiver
operating characteristic curve was calculated. Statistical analy-
ses were performed with the SPSS software package, ver-
sion 15.0 (SPSS, Chicago, IL, USA).
Results
During the study period, 466 patients met the inclusion
criteria. The main characteristics of the population are
summarized in Table 1.
In 183 (39.3%) of 466 patients undergoing PSFI, urine
culture was performed during the postoperative course
according to the treating clinician’s criteria. Eighty-nine
(19.1%) patients were ultimately diagnosed with UTI after a
median time of 8 days (IQR 6.75–11.25) from the index
surgery. Thirty-four patients (7.3%) had been preoperatively
treated for UTI and received broad-spectrum antibiotic
prophylaxis.
SSI was diagnosed in 54 of 466 (11.6%) patients (29 deep; 25
superﬁcial) after a median time from surgery of 14.5 days
(IQR 8–22). The SSI rate was 24.7% (22/89) in patients with
conﬁrmed UTI and 8.5% in those without UTI (32/377)
(p <0.05). The causal microorganisms were Gram-positive
bacteria in 29 of the 54 SSI cases (53.7%), GNB in 21 cases
(38.9%), and mixed ﬂora in four (7.4%) cases (Fig. 1).
Twenty-two of the 466 (4.7%) patients presented both UTI
and SSI, within a median time of 3.5 days (IQR 1.75–18.25),
and, in nine of the 22 (40.1%), the same microorganism was
isolated in urine and surgical site cultures (Table 2). Of the
nine patients with these two infections with the same
microorganisms, three had neurogenic bladder, and only one
had bacteraemic UTI. Among the 21 patients with SSIs caused
by GNB (Fig. 1), the same microorganism was isolated in the
two infections in eight (38.1%) patients.
A logistic regression model was ﬁtted to assess whether
postoperative UTI was associated with SSI (Table 3). On
univariate analysis, numerous factors were found to be
associated with SSI, including age, UTI, instrumentation more
than three segments, ASA score of >2, no urine studies
performed, and surgery for tumour. On multivariate analysis,
the variable ‘no urine studies’ was not included, because of its
interaction with UTI (all patients who did not have a urine
study were classiﬁed as not having UTI). After adjustment for
age and diagnosis (tumour), UTI (OR 3.1, 95% CI 1.6–6.1;
p 0.001) and instrumentation of more than three segments
(OR 2.7, 95% CI 1.1–6.3; p 0.024) were signiﬁcantly associ-
ated with SSI (Table 3). The performance of the ﬁnal model
based on the Hosmer–Lemeshow goodness-of-ﬁt C-test was
good (v2 = 7.2, p 0.52). The area under the receiver operating
characteristic curve for the ﬁnal model was 0.73
(95% CI 0.67–0.80; p <0.0001).
TABLE 1. Demographics and characteristics of patients
included in the study (N = 466 cases, otherwise indicated)
Characteristics N = 466 (100%)
Median age in years (IQR) 53.8 (33.8–65.6)
Female sex, no. (%) 273 (58.6)
ASA score of >2, no. (%) 190 (40.8)
Instrumentation >3, no. (%) 232 (49.8)
UTI, no. (%) 89 (19.1)
No urinary studies performed,no. (%) 283 (60.7)
Incontinency, no. (%) 100 (21.5)
Fusion to sacrum, no. (%) 158 (33.9)
Diagnosis, no. (%)
Deformity 110 (23.6)
Degenerative 235 (50.4)
Tumour 32 (6.9)
Fracture 89 (19.1)
ASA, American Society of Anesthesiologists; IQR, interquartile range; UTI, urinary
tract infection.
FIG. 1. Urine studies performed during the postoperative course in
54 patients with SSIs and type of microorganism identiﬁed from SSIs.
GNB, Gram-negative bacteria; G+, Gram-positive cocci; SSI, surgical
site infection; UTI, urinary tract infection.
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Regarding antibiotic treatment, ciproﬂoxacin was the
treatment of choice for UTI in 13 of the 22 patients who
had both infections (54.6%), followed by amoxycillin–clavulanic
acid in three cases. Six of the 13 (46.2%) patients who had
been treated with ciproﬂoxacin for UTI had SSI caused by
ciproﬂoxacin-resistant strains. Only seven of the 31 (21.9%)
patients who did not receive prior ciproﬂoxacin showed
ciproﬂoxacin-resistant microorganisms on wound culture. The
difference in these percentages did not reach statistical
signiﬁcance (p 0.1), but the statistical power was very low
(37.3%), owing to the small sample size.
Discussion
Our ﬁndings show a signiﬁcant association between UTI and
SSI: 16.7% (9/54) of SSI cases had UTI caused by the same
microorganism that caused SSI. Furthermore, in cases of SSI
TABLE 2. Characteristics and microbiological aetiology of concomitant surgical site infection (SSI) and urinary tract infection
(UTI) in 22 patients
Microorganism
causing UTI Antibiotic for UTI
Microorganism
causing SSI
Same/different
microroganismcausing
UTI and SSI
Time from
UTI to SSI
(days)
Type of infection
(deep or superﬁcial)
Sensitivity of strains
cultured at surgical
site to antibiotic
administered for UTI
Escherichia coli,
Klebsiella
Ciproﬂoxacin E. coli, Enterobacter Same 3 Deep S
E. coli Ciproﬂoxacin E. coli Same 1 Superﬁcial S
E. coli Ciproﬂoxacin E. coli Same 2 Deep R
Pseudomonas Ciproﬂoxacin Pseudomonas Same 2 Superﬁcial S
E. coli Amoxycillin–clavulanate E. coli Same 4 Deep R
Pseudomonas Piperacillin–tazobactam Pseudomonas, Klebsiella Same 1 Superﬁcial S
Klebsiella Ciproﬂoxacin Klebsiella Same 11 Deep S
E. coli Ciproﬂoxacin E. coli Same 22 Superﬁcial S
Enterococcus
faecalis
Piperacillin–tazobactam Enterococcus faecalis Same 5 Deep S
Klebsiella Amoxycillin–clavulanate Enterobacter Different 1 Superﬁcial R
E. coli, Proteus Ciproﬂoxacin Stenotrophomonas
maltophilia
Different 26 Superﬁcial R
E. coli Ciproﬂoxacin MRSA Different 30 Deep R
Citrobacter Ciproﬂoxacin CNS Different 9 Superﬁcial S
E. coli Amoxycillin–clavulanate Staphylococcus aureus Different 4 Superﬁcial R
Klebsiella Treatment started
simultaneously
for both UTI and SSI
S. aureus Different 0 Superﬁcial
E. coli Cefepime S. aureus Different 3 Superﬁcial S
Enterococcus
faecalis
Ciproﬂoxacin S. aureus Different 29 Deep R
E. coli Ciproﬂoxacin Corynebacterium Different 3 Deep S
Pseudomonas,
Enterobacter
Ceftazidime–ciproﬂoxacin CNS Different 3 Superﬁcial S
E. coli ESBL Imipenem S. aureus Different 22 Deep S
E. coli Ciproﬂoxacin S. aureus Different 1 Deep R
E. coli Cefuroxime Staphylococcus epidermidis Different 17 Deep R
CNS, coagulase-negative staphylococcus; ESBL, extended-spectrum b-lactamase; MRSA, methicillin-resistant Staphylococcus aureus; R, resistant; S, sensitive.
TABLE 3. Univariate and multivariate predictors of surgical site infection (SSI) in patients undergoing posterior spinal fusion and
instrumentation
Variables
Patients with
SSI (N = 54)
Patients without
SSI (n = 412)
Univariate analysis Multivariate analysis
OR 95% CI p-value OR 95% CI p-value
Age in years, median (IQR) 57.8 (37.6–71.6) 52.5 (33.2–65.3) 1.02 1.0–1.04 0.063 1.02 1.0–1.04 0.055
Female sex 32 241 1.03 0.6–1.8 0.915 – – –
UTI 29 67 3.54 1.9–6.5 0.000 3.1 1.6–6.1 0.001
Instrumentation >3 segments 41 191 3.6 1.9–7.0 0.000 2.7 1.1–6.3 0.024
ASA score of >2 29 161 1.9 1.1–3.3 0.03 0.9 0.5–1.9 0.961
No urinary studies during
postoperative course
15 144 0.25 0.21–0.3 0.000 – – –
Incontinence 16 84 1.6 0.9–3.1 0.12 – – –
Fusion to sacrum 17 141 0.8 0.5–1.6 0.69 – – –
Diagnosis
Deformity 18 92 2.0 0.8–4.8 0.13 2.0 0.7–5.2 0.155
Degenerative 19 216 0.9 0.4–2.1 0.8 1.6 0.5–4.8 0.397
Tumour 9 23 3.9 1.4–11.4 0.01 2.9 0.9–9.4 0.063
Fracture 8 81 – – – – – –
ASA, American Society of Anesthesiologists; IQR, interquartile range; UTI, urinary tract infection.
The bold values are statistically signiﬁcant.
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caused by Gram-negative bacteria, UTI caused by the same
microorganism was observed in 38% (8/21) of patients.
Nonetheless, the association between UTI and SSI probably
has a multifactorial explanation, and it cannot be inferred that
UTI is a direct risk factor for SSI in all cases. Although the
presence of preoperative UTI has been linked to a higher risk
of postoperative SSI, to the best of our knowledge there are
currently no studies that have analysed the potential risk of SSI
in patients with UTI after instrumented spinal surgery.
Local wound contamination by GNB can occur in inconti-
nent patients undergoing surgery in the lumbosacral area,
when microorganisms from the urinary tract directly reach the
surgical wound postoperatively. Contamination can also occur
during the surgical incision in incontinent patients with perineal
skin colonization with enteric or urogenic microorganisms
undergoing surgery at the lumbosacral region. In our sample,
however, fusion extending to the sacrum, which was per-
formed in 33.9% of patients, was not signiﬁcantly related to SSI.
Alternatively, microorganisms might reach the wound through
haematogenous seeding from a urinary source. This is probably
an uncommon route for acquiring SSI, and, in our sample, only
one patient with UTI and SSI had bacteraemia with positive
blood cultures. The two infections were simultaneous, and
samples were taken in the same time frame.
Regarding other factors related to SSI, we observed that
patients with longer instrumentations had signiﬁcantly higher
SSI rates, in accordance with the results of previous studies
[11,12]. This factor has also been linked to higher transfusion
requirements [13], which have modulatory effects on the
recipient’s immune system, increasing the risk of nosocomial
infection [14]. It is likely that mobilization is delayed in patients
with longer instrumentation and duration of catheterization,
factors that would facilitate the development of UTI. Tumour
surgery has been related to higher rates of nosocomial
infection (including UTI and SSI) [15]. In our sample, tumours
accounted for only 6.9% of cases, and this may be the reason
why this factor did not reach statistical signiﬁcance in the ﬁnal
model.
Regarding the performance of urine studies during the
postoperative course, we found that patients who did not
undergo urine study had a four-fold lower risk of developing
SSI than patients who presented UTI. Although some UTIs may
have been missed, these ﬁndings suggest that urine testing on a
routine basis to rule out postoperative UTI is probably
unnecessary, and would not be effective in preventing further
SSI. Therefore, we do not recommend routine urine culture
for SSI prevention in asymptomatic patients; instead, urine
culture should be based on clinical criteria, including speciﬁc
questioning about symptoms (e.g. fever, dysuria, and fre-
quency) during the physician’s daily rounds.
In nine cases (16.7% of the total SSIs), the same microor-
ganism was isolated in both urine and wound cultures,
although we cannot guarantee that the same strains were
present in both infections, because pulsed-ﬁeld gel electro-
phoresis studies were not performed. In view of the delete-
rious consequences that SSI can have after instrumented spinal
surgery [16], we believe that it is worthwhile taking these
ﬁndings into consideration, as speciﬁc measures to minimize
the risk of surgical wound contamination from a urinary source
can be easily taken without a signiﬁcant increase in cost. After
evaluating the results of the current study, we increased the
prophylactic measures used in these patients, including isola-
tion of the wound with speciﬁc dressings in incontinent
patients, particularly when surgery involved the lower lumbar
spine. In selected cases, mainly women with difﬁculty getting
out of bed without help, we chose to prolong catheterization
for 1 or 2 days, despite the higher risk of UTI in patients with
short-term catheterization [17]. The impact of these measures
remains to be evaluated.
Empirical antibiotic treatment is routinely started after
culture samples are taken. In nine of 21 patients (42.9%), the
microorganism cultured from SSIs were resistant to the
empirical antibiotic therapy administered for UTI treatment
(Table I), and 46.1% of patients who received ciproﬂoxacin for
UTI had resistance to this drug in SSIs. Resistance to
ciproﬂoxacin is increasing in our setting with 50% of Escherichia
coli catheter-associated UTIs in our hospitalized patients being
caused by ciproﬂoxacin-resistant microorganisms [17, 18].
These data and the results of our study, which show that almost
half of the SSIs in patients who had received ciproﬂoxacin were
resistant to this drug, suggest that these antibiotics should not
be used for empirical therapy in our setting. Quinolones have
shown to signiﬁcantly increase survival in patients treated for
prosthetic joint infections caused by GNB [20, 21]. As
quinolones are paramount on treatment of implant-associated
bony infections, they should not be used to treat UTI
empirically, in order to avoid resistances. Antibiotic treatments
modify the patient’s ﬂora, facilitating the growth of resistant
microorganisms [22], and it is known that antibiotic resistance
rates are directly related to their rate of use in a speciﬁc setting.
Alternative antibiotics for UTI, such as b-lactams, aminoglyco-
sides, or fosfomycin, may be recommended, depending on the
resistance pattern of each hospital setting.
Our study has the limitations and weaknesses of retrospec-
tive designs, and urine culture was only performed in symp-
tomatic patients; hence, some UTIs may have been overlooked.
The lack of reliable data on catheterization time or the patients’
baseline comorbidity (e.g. diabetes mellitus and body mass
index) precludes evaluation of the potential inﬂuence of these
factors on the presentation of both UTI and SSI.
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In conclusion, our study shows that postoperative UTI is
signiﬁcantly associated with SSI after posterior instrumented
spinal surgery, particularly SSI caused by Gram-negative
microorganisms. Further efforts to reduce the incidence of
UTI and to provide adequate empirical antibiotic therapy that
avoids quinolones may help to reduce SSI rates.
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